Magnolol Protects against MPTP/MPP<sup><b>+</b></sup>-Induced Toxicity via Inhibition of Oxidative Stress in <i>In Vivo</i> and <i>In Vitro</i> Models of Parkinson’s Disease

<table>Structures of magnolol and honokiol.</table>

Parkinson’s Disease

fig1

Figure 1

Figure 1: Magnolol Protects against MPTP/MPP<sup><b>+</b></sup>-Induced Toxicity via Inhibition of Oxidative Stress in <i>In Vivo</i> and <i>In Vitro</i> Models of Parkinson’s Disease 

Figure 1 | Magnolol Protects against MPTP/MPP+-Induced Toxicity via Inhibition of Oxidative Stress in In Vivo and In Vitro Models of Parkinson’s Disease 